BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4098770)

  • 1. [Methods for the conduction and control of thrombolytic therapy].
    Remde W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):165-70. PubMed ID: 4098770
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.
    Latallo ZS; Lopaciuk S
    Thromb Diath Haemorrh Suppl; 1973; 56():253-64. PubMed ID: 4617332
    [No Abstract]   [Full Text] [Related]  

  • 4. The hematologic consequences of thrombolytic therapy.
    Fletcher AP; Alkjaersig NK
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic use of thrombolytic agents.
    Stambaugh RL; Alexander MR
    Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current state and success of thrombolytic therapy].
    Deutsch E; Denk H; Fischer M
    Wien Med Wochenschr; 1969 Feb; 119(5):85-9. PubMed ID: 4891686
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracoronary thrombolytic (streptokinase) therapy of acute myocardial infarction in a community hospital; report of eleven consecutive cases.
    Mackie RW; Freeman DJ
    Wis Med J; 1983 Jan; 82(1):15-7. PubMed ID: 6829188
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myocardial revascularization in the developing phase of myocardial infarction using intracoronary thrombolytic therapy].
    Puel J; Miquel JP; Massabuau P; Cassagneau B; Miluau S; Fauvel JM; Bounnoure JP
    Rev Med Univ Navarra; 1984 Dec; 28(4):43-6. PubMed ID: 6528151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activator time. A method for control of activator activity during thrombolytic therapy.
    Blix S
    Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biologic data furnished by the experience of thrombolytic treatments with streptokinase].
    Samama M; Yver J; Casubolo L; Soria J; Bousser J
    Nouv Rev Fr Hematol; 1968; 8(1):84-92. PubMed ID: 4232155
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolytic therapy of patients with pulmonary artery thromboembolism by tissue plasminogen activator and streptokinase preparations].
    Ardashev VN; Sokolianskiĭ NV; Bystrov VV
    Klin Med (Mosk); 2000; 78(12):28-30. PubMed ID: 11210347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic therapy of acute myocardial infarct].
    De Giorgi E
    Minerva Cardioangiol; 1972 Nov; 20(11):663-6. PubMed ID: 4643520
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial infarction.
    Bradley JP
    N Z Med J; 1999 May; 112(1088):191. PubMed ID: 10391649
    [No Abstract]   [Full Text] [Related]  

  • 16. Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction.
    Walker ID; Davidson JF; Rae AP; Hutton I; Lawrie TD
    Thromb Haemost; 1984 Apr; 51(2):204-6. PubMed ID: 6377564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical use of thrombolytic agents].
    Laprevote-Heully MC; Lambert H; Larcan A
    Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombolytic treatment with streptokinase in recent myocardial infarct].
    Pagnoni D
    Cardiol Prat; 1970 Dec; 21(6):405-9. PubMed ID: 4101064
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytic therapy. I. Introduction and principles of therapy. Indications. Contraindications. Schematics of the treatment].
    Sterkowicz S
    Przegl Lek; 1969; 25(8):565-8. PubMed ID: 4897431
    [No Abstract]   [Full Text] [Related]  

  • 20. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
    Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
    Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.